Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Induced expression method of recombinant human endostatin

An endostatin, induced expression technology, applied in the direction of microorganism-based methods, biochemical equipment and methods, fermentation, etc., can solve the problems of inability to obtain expression, increased tolerance of inducers, and inability to obtain higher induced expression, etc. to meet the requirements of large-scale production and avoid the effect of increased tolerance

Active Publication Date: 2014-08-20
DENOVO BIOPHARMA HANGZHOU LTD
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] If the above-mentioned method is adopted in large-scale industrial production, a large amount of culture medium and culture solution will be consumed to keep the cell concentration of the bacterial fermentation liquid at a low level, while increasing the cell concentration and synchronously increasing the amount of the inducer. Not only will the engineering bacteria of recombinant human vascular endostatin rapidly increase their tolerance to the inducer, but their sensitivity will decrease significantly, and then the phenomenon of inducing the expression of recombinant human vascular endostatin protein will inevitably decrease, and it will not be possible to obtain At the same time, at the same time, under the high concentration of bacteria, the culture medium and culture solution with higher concentration are also required, and the bacteria must grow faster in this environment, and the nutrients are easy to be exhausted prematurely. Cause premature aging of bacteria and autolysis, unable to obtain ideal expression
In either case, it means that the production efficiency of recombinant human endostatin in large-scale production is extremely low, which will cause a large amount of raw material consumption
Therefore, although the expression amount of the above-mentioned method can reach 38%, the expression amount can only be obtained in a small amount of culture fluid and the OD of the fermentation broth. 600nm The value is realized under the condition of 0.4-0.6. In other words, the above method can only achieve high-efficiency induction expression at low concentration of engineering bacteria in small experiments, and then obtain a very small amount of product, which cannot be applied to industrialization

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Induced expression method of recombinant human endostatin
  • Induced expression method of recombinant human endostatin

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] In the method for inducing expression of recombinant human endostatin described in this example, at first the engineered bacteria are amplified in LB medium, and then inoculated into a 50L fermenter with an inoculation amount of 6% of the fermentation volume. In the fermentation medium, the volume of the fermentation liquid is 44L, and it is fermented to OD 600 The value is 12.5, then, add 3.75g of inducer IPTG, 13g / L of carbon source substance glucose, and 5g / L of nitrogen source substance yeast extract to it, cultivate at 30°C for 2.5h, and then add 2.4g inducer IPTG, continue to culture for 4h.

[0019] Wherein, the fermentation medium is composed of 10g / L tryptone, 20g / L yeast extract, 12.5g / L hydrolase protein, 1g / LKH 2 PO 4 , 10g / L glucose composition.

Embodiment 2

[0021] In the method for inducing expression of recombinant human endostatin described in this example, at first the engineered bacteria are amplified in LB medium, and then inoculated into a 50L fermenter with an inoculation amount of 5% of the fermentation volume. In the fermentation medium, the volume of the fermentation liquid is 44L, and it is fermented to OD 600 The value is 10. Then, add 2.49g of inducer IPTG, 15g / L of carbon source glucose, and 6g / L of nitrogen source yeast extract to it, cultivate at 34°C for 3h, and then add 3.75 g inducer IPTG, continue to culture for 3h.

[0022] Wherein, the fermentation medium is composed of 5g / L tryptone, 25g / L yeast extract, 7.5g / L hydrolase protein, 9g / LKH 2 PO 4 , 20g / L glucose composition.

Embodiment 3

[0024] In the method for inducing expression of recombinant human endostatin described in this example, at first the engineered bacteria are amplified in LB medium, and then inoculated into a 50L fermenter with an inoculation amount of 8% of the fermentation volume. In the fermentation medium, the volume of the fermentation liquid is 44L, and it is fermented to OD 600 The value is 15, and then, add 4.99g of inducer IPTG, 12g / L of carbon source glucose, and 4g / L of nitrogen source yeast extract to it, cultivate at 37°C for 3.5h, and then add 1.25g of the inducer IPTG, and continue to culture for 5h.

[0025] Wherein, the fermentation medium is composed of 15g / L tryptone, 15g / L yeast extract, 17.5g / L hydrolase protein, 5g / LKH 2 PO 4 , 15g / L glucose composition.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
concentrationaaaaaaaaaa
Login to View More

Abstract

The invention discloses an induced expression method of recombinant human endostatin. The method comprises the following steps: fermenting engineering bacteria until the OD600 value of fermentation liquor is 10-15, adding an inducer isopropyl-beta-d-thiogalactoside (IPTG), a carbon source substance and a nitrogen source substance, so that the concentration of the IPTG in the fermentation liquor is 0.2-0.4mmol / L; cultivating at 30-37 DE C for 2.5-3.5 hours; adding the inducer IPTG, so that the concentration of the IPTG in the fermentation liquor is 0.1-0.3mmol / L, and continuing to cultivate for 3-5 hours. By adopting the induced expression method of the recombinant human endostatin disclosed y the invention, the requirements of large-scale production of the recombinant human endostatin can be met, and efficient induced expression is achieved at high cell concentration.

Description

technical field [0001] The invention belongs to the field of extraction and purification of recombinant human vascular endostatin, and specifically relates to a method for inducing expression of recombinant human vascular endostatin. Background technique [0002] Human vascular endostatin is currently the most effective inhibitor of tumor angiogenesis with the best experimental effect. Experiments have shown that endostatin can inhibit vascular endothelial cells and growing blood vessels, and can better inhibit tumor growth and metastasis. In terms of its mechanism of action, human endostatin inhibits the blood supply of tumor tissue in the human body, causing the tumor to lack nutrients and oxygen and stop growing, and then gradually shrink until death. , has the advantage of no obvious toxic and side effects, and thus has received extensive attention from the medical community. [0003] At present, human endostatin is mainly prepared by obtaining engineering bacteria car...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12P21/02C12R1/19
Inventor 荣志刚姚建林赵唯一黄佩华朱浩文陈卫崔志远徐霞
Owner DENOVO BIOPHARMA HANGZHOU LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products